The "Lollipop" During Catheter-Directed Thrombectomy: 2 Case Examples
- PMID: 36684029
- PMCID: PMC9847234
- DOI: 10.1016/j.jaccas.2022.09.029
The "Lollipop" During Catheter-Directed Thrombectomy: 2 Case Examples
Abstract
Intraprocedural embolization has been described as a potential complication of catheter thrombectomy for acute pulmonary embolism and may be under-recognized. We describe 2 case examples of "Lollipopping" during thrombectomy, which may be a mechanism of intraprocedural embolization and describe our treatment approach. (Level of Difficulty: Advanced.).
Keywords: IVC, inferior vena cava; PE, pulmonary embolism; RHC, right heart catheterization; complication; pulmonary circulation; thrombus.
© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Conflict of interest statement
Dr Sethi has received honoraria from Janssen and Chiesi Inc. Dr Leon has served as a nonpaid advisory board member and receives institutional clinical research grants from Abbott, Boston Scientific, Medtronic, and Sinomed. Dr Kirtane has received institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Amgen, CSI, Philips, ReCor Medical, Neurotronic, Biotronik, Chiesi, Bolt Medical, Magenta Medical, Canon, SoniVie, and Merck (institutional funding includes both research grants and fees paid to Columbia University and/or Cardiovascular Research Foundation for consulting and/or speaking engagements in which Dr Kirtane controlled the content); has served as a consultant for IMDS; and has received travel expenses/meals from Medtronic, Boston Scientific, Abbott Vascular, CSI, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. Dr Parikh has received institutional grants/research support from Abbott Vascular, Shockwave Medical, TriReme Medical, Sumodics, Silk Road Medical, and the National Institutes of Health; has received consulting fees from Terumo and Abiomed; and has served on the Advisory Boards of Abbott, Medtronic, Boston Scientific, CSI, Janssen, and Philips. Dr Finn has received speaker fees from Janssen. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures




References
-
- Giri J., Sista A.K., Weinberg I., et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation. 2019;140(20):e774–e801. doi: 10.1161/CIR.0000000000000707. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources